1. Introduction
===============

Asthma is a complex inflammatory disorder which characterized by airway inflammation and hyper-responsiveness, hyper-secretion of mucus by goblet cells and eosinophilic inflammation \[[@b1-2093-6966-v22-n03-122]\]. Asthma is triggered by a very complex interaction between high serum levels of immunoglobulin E (IgE) and production of inflammatory mediators such as; interleukin (IL)-4, IL-5, and IL-13 by T-helper 2 (Th2) cells \[[@b2-2093-6966-v22-n03-122]\]. Asthma disease could be as a result of airway inflammation \[[@b3-2093-6966-v22-n03-122]\] and smooth muscle dysfunction \[[@b4-2093-6966-v22-n03-122]\]. Corticosteroids inhibiting eosinophil function and bronchodilator drugs contribute to the treatment of asthma \[[@b5-2093-6966-v22-n03-122], [@b6-2093-6966-v22-n03-122]\]. It has been reported that combination therapy with corticosteroids and β-agonists reduced tracheal hyper-responsiveness and lung inflammation in ovalbumin sensitized animal model \[[@b7-2093-6966-v22-n03-122], [@b8-2093-6966-v22-n03-122]\].

Medicinal plants used in traditional medicine have been revealed to treatment of various inflammatory disorders such as asthma. The medicinal plants used for asthma should have anti- inflammatory, antihistaminic, immunomodulatory and smooth-muscle relaxants activity\[[@b9-2093-6966-v22-n03-122]\]. Portulaca oleracea (P. oleracea) or Purslane belongs to the Portulacaceae family ([Fig. 1](#f1-2093-6966-v22-n03-122){ref-type="fig"}). This plant is an annual and grassy plant with small-yellow flowers, which grows in different areas of the world including; Southern Europe, Indies, China, Japan, north and north-west of Iran \[[@b10-2093-6966-v22-n03-122]\].

*P. oleracea* has several pharmacological effects including; neuroprotective \[[@b11-2093-6966-v22-n03-122]\], hepatoprotective \[[@b12-2093-6966-v22-n03-122]\], antioxidant \[[@b13-2093-6966-v22-n03-122]\], anti-inflammatory \[[@b14-2093-6966-v22-n03-122]\] and immunomodulatory effects \[[@b15-2093-6966-v22-n03-122]\]. In this review, we reviewed the anti-asthmatic properties of P. oleracea with several mechanisms such as anti-inflammatory, smooth muscle relaxant and antioxidant effects.

2. Methods
==========

The databases such as, PubMed, Scopus and Google Scholar were considered for searching until the end of Jul 2018. The search terms "Portulaca oleracea", "Quercetin", "Anti-inflammatory", "Cytokines", "Smooth muscle ", " Relaxant effects" and "antioxidant" were used. All studies such as, in vitro studies, animal studies, review articles and clinical studies were included. Letter to Editor and unpublished data were the exclusion criteria.

3. Constituents of P.oleracea
-----------------------------

*P. oleracea* or Purslane contains omega-3 fatty acids and alpha-linolenic acid more than other leafy vegetable plant \[[@b16-2093-6966-v22-n03-122]\]. It also has 0.01 mg/g of eicosa-pentaenoic acid (EPA). EPA is an Omega-3 fatty acid found mostly in fish and some algae. Purslane contains vitamins as well as nutritive minerals such as iron, magnesium, potassium, and calcium. Purslane also contains potent antioxidants and anti-mutagenic agents including betalain alkaloid pigments and the yellow betaxanthins \[[@b17-2093-6966-v22-n03-122]\] as well as flavonoids (kaempferol, apigenin, myricetin, portulacanones A, B, C and D), alkaloids (opleraceins A, B, C, D and E), fatty acids, terpenoids (portuloside A and B), polysaccharides, and vitamins \[[@b18-2093-6966-v22-n03-122]\].

4. Anti-inflammatory and antioxidant effects
============================================

4.1. P.oleracea
---------------

The hydro-ethanolic extracts (10, 40 and 160 μg/ml) of P. oleracea significantly increased IFN-γ, IFN-γ/IL-4 ratio and IL-10/IL-4 ratios in non-stimulated and stimulated human lymphocytes cells. In stimulated lymphocytes, the extract of P. oleracea significantly decreased inflammatory cytokines such as, IL-4, IL-10 and free radicals such as nitric oxide (NO). In addition administration of P. oleracea extract significantly increased IFN-γ/IL-4 and IL-10/IL-4 \[[@b19-2093-6966-v22-n03-122]\]. The aqueous extracts of P. oleracea (10, 25, 50 and 100 μg/ml) in a dose- dependent manner significantly inhibited TNF-α-induced intracellular reactive oxygen species (ROS) production. P. oleracea also suppressed the TNF-α-induced degradation of IκB-α and reduced the TNF-α-induced NF-κB binding protein in the vascular endothelial cells. The plant extracts in a dose-dependent manner also effectively reduced mRNA expression of Monocyte chemoattractant protein-1 (MCP-1) and IL-8 caused by TNF-α \[[@b20-2093-6966-v22-n03-122]\]. The ethanol extract of P. oleracea (50, 100 and 200 μg/ml) inhibited production of inflammatory mediators such as NO and pro-inflammatory cytokines including; TNF-α, IL-1β and IL-6 in LPS-induced inflammation in RAW 264.7 cells (derived from BALB/c mice). In addition, P. oleracea extract inhibited the phosphorylation of (ERK1/2), c-Jun NH2-terminal kinase (JNK) and NF-κB activation in cells \[[@b21-2093-6966-v22-n03-122]\]. POL-P3b as a polysaccharide fraction purified from P. oleracea) (250 μg/ml) up-regulated the expression of CD80, CD86, CD83, and stimulated production of more IL-12, TNF-α, and less IL-10 on the maturation and function of murine bone-marrow-derived dendritic cells (DCs). Moreover, POL-P3b significantly increased the expression of Toll-like receptor 4 (TLR-4) on DCs treated. These results suggested that POL-P3b may induce DCs maturation through TLR-4 \[[@b22-2093-6966-v22-n03-122]\]. The orally administration of P. oleracea polysaccharides (100, 200, 300, 400, 500 and 600 μg/ml) significantly increased stimulation indices (SI) of T lymphocytes and B lymphocytes dose-dependently in Wistar rats \[[@b23-2093-6966-v22-n03-122]\]. The polysaccharide (POP) from P. oleracea showed preventive effect on reduction of the spleen weight and the number of murine spleen T cells after 30 days of inducing age in the mice with D-galactose \[[@b24-2093-6966-v22-n03-122]\].

Besides anti-inflammatory effect, P. oleracea has been shown to have antioxidant effects \[[@b25-2093-6966-v22-n03-122]\]. It has been reported that P. oleracea improves oxidative stress in vitamin A deficient rats \[[@b26-2093-6966-v22-n03-122]\]. Researchers also documented that hydro- ethanolic extract of P. oleracea decreased the serum level of oxidant agents such as NO2, NO3 and malondialdehyde (MDA) and enhanced the serum level of antioxidant parameters such as superoxide dismutase (SOD) and catalase (CAT) in sensitized rats. It has been indicated that this effect of P. oleracea is comparable with effect of dexamethasone \[[@b27-2093-6966-v22-n03-122]\]. In addition, it has been documented that pretreatment with extract of P. oleracea ameliorated oxidative stress in streptozotocin-induced diabetic rats via reducing MDA concentration and enhancing the level of glutathione (GSH). In another study, ethanol extract of P. oleracea has been shown to protect the lungs of mice exposed to hypoxia due to its antioxidant effects \[[@b28-2093-6966-v22-n03-122]\]. The ethanol extract of P. oleracea reduced ROS and MDA level in the lung tissue and enhanced the level of GSH and SOD when it was orally (100, 200 and 400 mg/kg) injected \[[@b29-2093-6966-v22-n03-122]\]. In addition, P. oleracea has been reported to a significant increase in level of glutathione peroxidase (GPx), glutathione- S-transferase (GST) and glutathione reeducates (GR) in hepatic and renal tissues of rats \[[@b30-2093-6966-v22-n03-122]\].

4.2. Quercetin
--------------

Quercetin (a natural flavonoid found in many vegetables and fruits including P. oleracea), dose dependently inhibited TNF-α production and attenuated the cytokines and chemokines production by LPS-stimulated DCs. The quercetin (6.25, 12.5, 50 and 100 μg/ml) treatment significantly decreased the generation of inflammatory cytokines such as IL-1 α, IL-1 β, IL-6, and IL-12 and chemokines such as MCP-1, MIP-1a, MIP-1b in LPS-stimulated DCs. Quercetin administration also significantly reduced the levels of CD40, CD80, and CD86 in DCs stimulated by LPS. Quercetin also down regulated the cytokines and chemokines secreted by activated DCs \[[@b31-2093-6966-v22-n03-122]\]. Quercetin (40 μM) suppressed gene transcription of IL-2 and IFN-γ cytokines while it could not attenuate IL-4 transcript. Quercetin has been shown to inhibit the increased expression of IL-2Ra in response to exogenous recombinant human IL-2 and TCR stimulation \[[@b32-2093-6966-v22-n03-122]\].

Quercetin (1, 10, 50 μM) inhibited the iNOS, TNF-α and IL-1β expression and IkB-α phosphorylation induced by LPS in bone marrow-derived macrophages (BMDM). In addition quercetin treatment (1 mg/kg/day, p.o.) in vivo, inhibited TNF-α, IL-1β and iNOS, expression induced by dextran sulfate sodium (DSS) in rats \[[@b33-2093-6966-v22-n03-122]\].

The level of eosinophils were significantly reduced 68.79% and 73.35% by quercetin (8 and 16 mg/kg/day, i.p, respectively) in Bronchoalveolar lavage fluid (BALF) of mice airway challenge with ovalbumin (OVA). Quercetin also reduced the concentration of IL-4, IL-5, and mRNA expression of matrix metallopeptidase-9 (MMP-9) and increased the concentration of IFN-γ in the BALF as compared to OVA-sensitized mice \[[@b34-2093-6966-v22-n03-122]\]. Anti-inflammatory effects of P. oleracea and quercetin were showed in the [Table 1](#t1-2093-6966-v22-n03-122){ref-type="table"}.

4.3. Alpha Linolenic Acid
-------------------------

Alpha linolenic acid (ALA) is considered as one of the main constituent of P. oleracea \[[@b35-2093-6966-v22-n03-122]\]. This omega-3 fatty acid has been reported to modulate the immune system function through affecting T lymphocytes \[[@b36-2093-6966-v22-n03-122]\]. It has been documented that ALA can enhance the level of eicosapentaenoic acid in the cell membrane as well as reduction of pro-inflammatory cytokines including IL-1 and TNF-α. These changes were associated with a reduction response to allergens in asthma \[[@b37-2093-6966-v22-n03-122]\]. Scientific evidence have also been indicated that treatment of sensitized rats with two concentration of ALA (0.2 and 0.4 mg/kg) resulted in a decrease in NO2, NO3 and MDA concentration and an increase in the serum level of thiol, SOD and CAT \[[@b27-2093-6966-v22-n03-122]\]. These reports confirm the anti-inflammatory and antioxidant of ALA.

4.4. Other constituents
-----------------------

Besides Flavonoids such as quercetin and fatty acids including ALA, P. oleracea possesses other several constituents such as alkaloids, terpenoids, vitamins, sterols, proteins and minerals \[[@b18-2093-6966-v22-n03-122]\]. Alkaloids presence such as dopa, dopamine and noradrenalin in leaves of P. oleracea has been confirmed \[[@b38-2093-6966-v22-n03-122]\]. Monoterpenes including portulosides A and B, as well as diterpens have been reported in extract of P. oleracea \[[@b39-2093-6966-v22-n03-122]\]. In addition, P. oleracea is a rich source of vitamins such as vitamin A, ascorbic acid and B-complex vitamins. Vitamin A and ascorbic acid are natural antioxidant found in P. oleracea \[[@b18-2093-6966-v22-n03-122], [@b40-2093-6966-v22-n03-122]\]. P. oleracea also contains several minerals including manganese, calcium and phosphorus as well as amino acids like proline, leucine, isoleucine, lysine, cysteine and tyrosine \[[@b41-2093-6966-v22-n03-122]\].

5. Smooth muscle relaxant effects
=================================

5.1. P. oleracea
----------------

The relaxant effect of P. oleracea on skeletal muscle \[[@b45-2093-6966-v22-n03-122]\] and smooth muscle \[[@b46-2093-6966-v22-n03-122]\] has been shown. In asthmatic patients, bronchodilatory effect of boiled extract of P.oleracea was evaluated. The results showed that boiled extract of P. oleracea significantly enhanced all measured pulmonary function tests (PFTs). It has been reported that this bronchodilatory effect is similar to theophylline syrup \[[@b46-2093-6966-v22-n03-122]\]. Aqueous extract of P. oleracea reduced pristaltic index by antagonistic effects on calcium channel in the isolated guinea pig ileum strip \[[@b47-2093-6966-v22-n03-122]\].

The Aqueous extract of the plant also showed relaxant effect on smooth muscle and reduced blood pressure in guinea pig fundus, rabbit jejunum and rabbit aorta \[[@b48-2093-6966-v22-n03-122]\]. The hydro-ethanolic extract of P. oleracea (0.06, 0.12 and 0.25 mg/ml) in dose depend manner showed a stimulatory effect on β-adrenoceptor in tracheal smooth muscles of guinea pigs \[[@b49-2093-6966-v22-n03-122]\]. The relaxant effect of P. oleracea on tracheal smooth muscles via blocking of muscarinic receptor was also investigated \[[@b50-2093-6966-v22-n03-122]\]. The researchers suggested that bronchodilatory effects of P. oleracea can attribute to stimulation of β2 adronceptors \[[@b51-2093-6966-v22-n03-122]\], stimulation of inhibitory non-adrenergic and non-cholinergic nervous system \[[@b46-2093-6966-v22-n03-122]\], opening potassium channels \[[@b52-2093-6966-v22-n03-122]\], inhibition of phosphodiestrase \[[@b53-2093-6966-v22-n03-122]\] and calcium antagonism \[[@b54-2093-6966-v22-n03-122]\]. Ethyl acetate (EA) of P. oleracea extract has been indicated to decrease intestinal motility in ICR mice receiving this fraction compared to those of treated with acetylcholine \[[@b55-2093-6966-v22-n03-122]\]. Based on the results of scientific studies, the aqueous extract of P. oleracea has been shown to ameliorate impairment of acetylcholine (Ach)- and sodium nitroprusside (SNP) induced vascular relaxant of aortic rings in diabetic db/db mice, which this improving effect is associated with a significant decrease in the level of vasoconstrictor endothelin (ET)-1. It has also been suggested that the aqueous extract of P. oleracea suppresses overexpression of vascular cell adhesion molecule (VCAM)-1, intracellular cell adhesion molecular (ICAM) - 1, E-selectin and matrix metalloproteinase (MMP)-2 in aortic tissue in db/db mice \[[@b56-2093-6966-v22-n03-122]\].

Extracted quercetin from P.oleracea has been proposed to have relaxant effect on smooth muscle of vascular endothelium which this effect is attributed to more release of prostaglandins than of nitric oxide (NO) from endothelium \[[@b57-2093-6966-v22-n03-122]\]. The mechanism of pharmacological action of P. oleracea on respiratory system were shown ([Fig. 4](#f4-2093-6966-v22-n03-122){ref-type="fig"}).

5.2. Quercetin
--------------

It has been reported that quercetin inhibits the contraction caused by phenylephrine in aorta of rat \[[@b58-2093-6966-v22-n03-122]\] as well as the contraction induced by anaphylaxis in guinea pig ileum \[[@b59-2093-6966-v22-n03-122]\]. Quercetin inhibited smooth muscle cells proliferation, G1 cell-cycle arrest, decreased in the kinase activities, inhibit TNF-a induced induction of MMP-9 enzyme activity, decreasing the nuclear factor kappa B (NF-kB) binding activity in Human aortic smooth muscle cells \[[@b60-2093-6966-v22-n03-122]\]. Scientific evidence demonstrated that quercetin suppressed the high KCl -- induced contractions and noradrenaline in rat isolated aorta \[[@b61-2093-6966-v22-n03-122]\]. The results of studies determined that quercetin inhibited smooth muscle cells proliferation and suppressed migration them from the media into intima \[[@b62-2093-6966-v22-n03-122]\]. In addition, quercetin (10--80μg/mL) inhibited the effect of TNF-α on DNA synthesis and ERK1/2 activation as well as inhibition of cyclin D1/CDK4 and cycline E/CDK2 activities in human aortic smooth muscle cells \[[@b60-2093-6966-v22-n03-122]\]. Quercetin has also been indicated to inhibit angiotensin II (Ang II) -- induced C-Jun N-terminal kinase (JNK) activation in cultured rat aorta smooth muscle which this inhibitory effect may be attributed to its antioxidant effects \[[@b63-2093-6966-v22-n03-122]\]. The relaxant effects of quercetin includes by inhibition of Ca+ 2 influx and release of Ca+ 2 from intracellular stores \[[@b57-2093-6966-v22-n03-122]\]. Quercetin enhanced relaxation of rat aortic ring segments \[[@b64-2093-6966-v22-n03-122]\]. This results indicated that quercetin-mediated stimulation of eNOS phosphorylation increases NO bioavailability in endothelial cells. Oral administration of quercetin significantly reduced hyperreactivity of airways smooth muscle in Guinea pig \[[@b65-2093-6966-v22-n03-122]\]. Smooth muscle relaxant effects of P. oleracea and quercetin were showed in the [Table 2](#t2-2093-6966-v22-n03-122){ref-type="table"}.

6. Clinical evidences
=====================

Therapeutic effects of P. oleracea in the airway of asthmatic patients showed that the oral admonition of 5% boiled extract (0.25 ml/kg) increased pulmonary function tests similar to theophylline \[[@b46-2093-6966-v22-n03-122]\]. Quercetin (0.5, 1, 10, 25, 50 μM) significantly induced the gene expression of IFN-γ and down regulated IL-4 in normal human peripheral blood mononuclear cell (PBMC). Additionally, treatment with quercetin increased the phenotypic expression of IFN-γ cells and decreased IL-4 in positive cells \[[@b42-2093-6966-v22-n03-122]\].

Quercetin (5, 10, 25, 50, 100, 200 μM) by itself and in combination with human IFN-β (50 μM+ IFN-β), in PBMC isolated from multiple sclerosis (MS) patients and from normal healthy subjects has been demonstrated to reduce the proliferation of PBMC and to modulate the level of IL-1β and TNF-α. The combination of quercetin with IFN-β, showed additive effects in modulating TNF-α and MMP-9. Furthermore, quercetin reduced the MMP-9/tissue inhibitor of metalloproteinases-1 (TIMP-1) ratio via lowering MMP-9 production in a dose-dependent manner. These effects of quercetin were similar between MS patients and healthy control subjects \[[@b43-2093-6966-v22-n03-122]\].

Oral administration of quercetin (1500 mg/day) in rheumatoid arthritis patients significantly reduced IL-6, C3 and C4 levels and elevated IL-10 level in treated group with quercetin plus 100 mg azathioprine, compared to treated group with azathioprine + placebo eight weeks after treatment \[[@b44-2093-6966-v22-n03-122]\].

7. Conclusion
=============

Asthma disease is characterized by airway inflammation and smooth muscle dysfunction. P. oleracea and quercetin reduced the production of NO, inflammatory cytokines and chemokines such as; IL-4, IL-1β, TNF-α, MMP-9 and TIMP-1. They also increased anti-inflammatory cytokines such as, IFN-γ and IL-10 in in vivo and in vitro studies. This plant and its component has also been shown to have relaxant effects on tracheal smooth muscle by stimulatory effects on β-adrenoceptor as well as inhibitory effects on muscarinic receptors in tracheal smooth muscles. The results of this review articles indicated P. oleracea and its constituents particularly quercetin have anti-inflammatory and smooth muscle relaxant effects and potential therapeutic effects on allergic asthma.

This paper meets the requirements of KS X ISO 9706, ISO 9706-1994 and ANSI/NISO Z39.48-1992 (Permanence of Paper).
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###### 

Anti-inflammatory and antioxidant effects of P. oleracea and its constituents

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Plants                       Extract                    Effective doses                                                                                     Model of study                                                                                Effects                                                                        Ref.
  ---------------------------- -------------------------- --------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ----------------------------------
  *P. oleracea*                Hydro-ethanolic            160 μg/ml                                                                                           Lymphocyte                                                                                    Increased IL-4, IL-10, IFN-γ, IFN-γ/IL-4 and IL-10/IL-4 ratios                 \[[@b19-2093-6966-v22-n03-122]\]

  Aqueous extract              100 μg/ml                  Vascular endothelial cells                                                                          Decreased mRNA expressions of MCP-1 and IL-8                                                  \[[@b20-2093-6966-v22-n03-122]\]                                               

  Ethanol                      200 μg/ml                  RAW 264.7 cells                                                                                     Decreased TNF-α, IL-1β and IL-6                                                               \[[@b21-2093-6966-v22-n03-122]\]                                               

  POL-P3b                      (250 μg/ml)                DCs                                                                                                 Increased IL-12, and IL-10                                                                    \[[@b22-2093-6966-v22-n03-122]\]                                               

  polysaccharide               600 μg/ml, p.o.            Rat                                                                                                 Increased T lymphocytes and B lymphocytes                                                     \[[@b23-2093-6966-v22-n03-122]\]                                               

  Hydro-ethanolic              1, 2 and 4 mg/mL, p.o.     Rats                                                                                                Decreased the serum level of NO2, NO3 and (MDA) and enhanced the serum level of SOD and CAT   \[[@b27-2093-6966-v22-n03-122]\]                                               

  Ethanol                      100 and 250 mg/kg          Mice                                                                                                Shown antioxidant effects on the lungs                                                        \[[@b28-2093-6966-v22-n03-122]\]                                               

  Ethanol                      100, 200, and 400 mg/kg    Mice                                                                                                Reduced ROS and MDA level in the lung tissue and enhanced the level of GSH and SOD            \[[@b29-2093-6966-v22-n03-122]\]                                               

  Component of *P. oleracea*   Quercetin                  100 μg/ml                                                                                           DCs                                                                                           Decreased IL-1α, IL-1 β, IL-6, IL-10, IL-12 p70) and MCP-1, MIP-1 a, MIP-1 b   \[[@b31-2093-6966-v22-n03-122]\]

  40 μM                        Th cells                   Decreased IL-2, IFN-γ and IL-2Ra expression                                                         \[[@b32-2093-6966-v22-n03-122]\]                                                                                                                                             

  50 μM                        PBMC                       Decreased IL-4\                                                                                     \[[@b42-2093-6966-v22-n03-122]\]                                                                                                                                             
                                                          Increased IFN-γ                                                                                                                                                                                                                                                                  

  50 μM+IFN-β                  PBMC                       Decreased IL-1β, TNF-α, MMP-9, and TIMP-1                                                           \[[@b43-2093-6966-v22-n03-122]\]                                                                                                                                             

  50 μM                        BMDM                       Decreased expression of iNOS, TNF-α, IL-1β and I~k~B-αphosphorylation                               \[[@b33-2093-6966-v22-n03-122]\]                                                                                                                                             

  1 mg/kg/day, p.o.            Rat                        Decreased TNF-α, IL-1β expression and iNOS                                                          \[[@b33-2093-6966-v22-n03-122]\]                                                                                                                                             

  1500 mg/day, p.o.            Human                      Decreased IL-6, ICAM-1 Increased IL-10                                                              \[[@b44-2093-6966-v22-n03-122]\]                                                                                                                                             

                               **Alpha Linolenic Acid**   0.2 and 0.4 mg/ml                                                                                   Rats                                                                                          Significantly decreased BALF levels of TP, PLA2, IgE and IL-4                  \[[@b37-2093-6966-v22-n03-122]\]

  0.2 and 0.4 mg/kg            Rats                       Decreased NO2, NO3 and MDA concentration and an increase in the serum level of thiol, SOD and CAT   \[[@b27-2093-6966-v22-n03-122]\]                                                                                                                                             
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

IL: interleukin, IFN-γ: Interferon Gama, POL-P3b: polysaccharide fraction, MCP-1: Monocyte chemoattractant protein-1, TNF-α: Tumor necrosis factor-α, NO: Nitrogen oxide, MDA: malondialdehyde, SOD: superoxide dismutase, CAT: catalase, MIP: Macrophage Inflammatory Proteins, MMP-9: Matrix Metalloprotienase-9, TIMP-1: Tissue inhibitors of metalloproteinases-1, iNOS: Inducible nitric oxide synthase, ICAM-1: Intercellular Adhesion Molecule 1. BALF: bronchoalveolar lavage fluid, TP: total protein, PLA2: phospholipase A2, IgE: immunoglobulin E.

###### 

Smooth muscle relaxant effects of P. oleracea and quercetin

  *Plants*                      Extract                            Effective doses                                                                                                                               Model of study                                                             Effects                                                          Ref.
  ----------------------------- ---------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------- ---------------------------------------------------------------- ----------------------------------
  *P. Oleracea*                 Aqueous extract                    0.25 mg/kg                                                                                                                                    Asthmatic patients                                                         Increased measured PFTs                                          \[[@b46-2093-6966-v22-n03-122]\]
  Boiled and aqueous extracts   Boiled (1.25ml) aqueous (6.25ml)   Tracheal chains of guinea pig                                                                                                                 Relaxant effect on tracheal chains                                         \[[@b66-2093-6966-v22-n03-122]\]                                 
  Ethanolic extract             (250 μg/ml)                        Mice                                                                                                                                          Reduced intestinal motility                                                \[[@b55-2093-6966-v22-n03-122]\]                                 
  Aqueous extract               600 μg/ml p.o.                     Isolated guinea pig ileum strip                                                                                                               Reduced pristaltic index                                                   \[[@b47-2093-6966-v22-n03-122]\]                                 
  Aqueous extract               7 × 10^−4^ g/ml                    Guinea pig fundus, rabbit jejunum and rabbit aorta                                                                                            Relaxant effect on smooth muscle and reduced blood pressure                \[[@b48-2093-6966-v22-n03-122]\]                                 
  Hydro-ethanolic                                                  Guinea pigs tracheal smooth muscles                                                                                                           Stimulatory effect on β-adrenoceptor and blocking of muscarinic receptor   \[[@b50-2093-6966-v22-n03-122], [@b67-2093-6966-v22-n03-122]\]   
  Component of *P. Oleracea*    Quercetin                          10^−4^ mol                                                                                                                                    Isolated rat aorta                                                         Vasodilator effect on Isolated rat aorta                         \[[@b61-2093-6966-v22-n03-122]\]
  10^−5^ mol                    Rat vascular smooth muscle         Inhibitory effect on phasic contractions                                                                                                      \[[@b68-2093-6966-v22-n03-122]\]                                                                                                            
  10--80 μg/ml                  Human aortic smooth muscle cells   Inhibit smooth muscle cells proliferation, inhibited TNF-a induced induction of MMP-9 enzyme activity, decreased the NF-kB binding activity   \[[@b60-2093-6966-v22-n03-122]\]                                                                                                            
  0.3 mm                        Rat aorta                          Vasorelaxant response                                                                                                                         \[[@b57-2093-6966-v22-n03-122]\]                                                                                                            
  5 and 10 μm                   Rat thoracic aortas                Reduced vasoconstrictor sensitivity in rat aortic ring                                                                                        \[[@b64-2093-6966-v22-n03-122]\]                                                                                                            
  20 mg/kg oral                 Guinea pig                         Relaxed tracheal smooth muscle                                                                                                                \[[@b65-2093-6966-v22-n03-122]\]                                                                                                            

PFT: pulmonary function tests, NF-kB: nuclear factor kappa B, TNF-α: Tumor necrosis factor-α, MMP-9: Matrix Metal-loprotienase-9.
